Category Archives: Top Market News
The SVP Global Op. of Align Tech (NASDAQ: ALGN) is Selling Shares
Yesterday, the SVP Global Op. of Align Tech (ALGN – Research Report), Emory Wright, sold shares of ALGN for $4.52M. Following Emory Wright’s last ALGN Sell transaction on October 28, 2020, the stock climbed by 261.8%. In addition to Emory
Verastem (VSTM) Gets a Buy Rating from Alliance Global Partners
In a report released today, Matthew Cross from Alliance Global Partners maintained a Buy rating on Verastem (VSTM – Research Report), with a price target of $6.00. The company’s shares closed last Monday at $3.21. According to TipRanks.com, Cross is
H.C. Wainwright Thinks Cocrystal Pharma’s Stock is Going to Recover
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Cocrystal Pharma (COCP – Research Report), with a price target of $4.00. The company’s shares closed last Monday at $1.15, close to its 52-week low
H.C. Wainwright Thinks Corvus Pharmaceuticals’ Stock is Going to Recover
In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Corvus Pharmaceuticals (CRVS – Research Report), with a price target of $6.00. The company’s shares closed last Monday at $2.14, close to its 52-week low
Analysts Offer Insights on Healthcare Companies: Minerva Neurosciences (NASDAQ: NERV), Angion Biomedica (NASDAQ: ANGN) and DBV Technologies SA – American (NASDAQ: DBVT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Minerva Neurosciences (NERV – Research Report), Angion Biomedica (ANGN – Research Report) and DBV Technologies SA – American (DBVT – Research Report)
H.C. Wainwright Thinks Mustang Bio’s Stock is Going to Recover
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Mustang Bio (MBIO – Research Report), with a price target of $7.00. The company’s shares closed last Monday at $2.79, close to its 52-week low
